Eosinophilic Disorders and Syndromes
Eosinophilic Disorders and Syndromes is a research topic within Rheumatology. Science Explorer counts 30k research works in it since 1950. 12.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the hypereosinophilic syndrome and related disorders, including the molecular pathogenesis, classification, and therapeutic management. It covers topics such as fusion genes (e.g., FIP1L1-PDGFRA), imatinib mesylate treatment, cardiac manifestations, and the classification of eosinophilic disorders.
- Hypereosinophilic Syndrome
- Fusion Genes
- Imatinib Mesylate
- Eosinophilia
- PDGFRA
- Classification
- Molecular Pathogenesis
- Cardiac Manifestations
- Therapeutic Management
- Eosinophilic Disorders
- Research works
- 30k fractional, since 1950
- In the world top 10%
- 3.8k per year above
- Top-10% rate
- 12.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +19% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Eosinophilic Disorders and Syndromes research?
By volume, the United States and China publish the most (1.4k and 480 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 China 480 works
- 3 Japan 357 works
- 4 India 265 works
- 5 Italy 264 works
- 6 Spain 181 works
- 7 Germany 180 works
- 8 France 170 works
- 9 United Kingdom 164 works
- 10 Brazil 121 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Eosinophilic Disorders and Syndromes research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Eosinophilic Disorders and Syndromes research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Mayo Clinic in Arizona.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 23 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 21 works
- 3 Mayo Clinic in ArizonaUnited States 18 works
- 4 University of North Carolina at Chapel HillUnited States 18 works
- 5 Cleveland ClinicUnited States 17 works
- 6 University of PaduaItaly 17 works
- 7 Mayo ClinicUnited States 15 works
- 8 Icahn School of Medicine at Mount SinaiUnited States 15 works
- 9 Istituti di Ricovero e Cura a Carattere ScientificoItaly 15 works
- 10 Mayo Clinic in FloridaUnited States 14 works
Who are the leading researchers in Eosinophilic Disorders and Syndromes?
The most-cited researchers publishing on Eosinophilic Disorders and Syndromes include Hagop M. Kantarjian.
- 1 Hagop M. Kantarjian United States 4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Eosinophilic Disorders and Syndromes research done?
The largest centres of Eosinophilic Disorders and Syndromes research in 2022–2025 are Beijing (China), Tokyo (Japan), New York (United States) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Cincinnati.
Largest cities, 2022–2025
Where it is the local speciality
- CincinnatiUS · 24.9 works6.8×
Location quotient: how much more of its research is in Eosinophilic Disorders and Syndromes than the world average.
Where is the best place to study Eosinophilic Disorders and Syndromes?
Among universities, judged by research, Icahn School of Medicine at Mount Sinai, University of Padua and University of North Carolina at Chapel Hill score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Icahn School of Medicine at Mount SinaiUnited States | 57.3 | 27.5% | 6.6× | 15 | +29.1% |
| 2 | University of PaduaItaly | 55.0 | 24.9% | 4.5× | 17 | +49.5% |
| 3 | University of North Carolina at Chapel HillUnited States | 53.9 | 37.0% | 2.3× | 18 | +42.3% |
| 4 | Harvard UniversityUnited States | 48.4 | 29.8% | 2.3× | 13 | +19.1% |
| 5 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 47.7 | 12.6% | 4.8× | 21 | +65.1% |
| 6 | University of Colorado DenverUnited States | 45.9 | 23.6% | 6.9× | 10 | +18.1% |
| 7 | University of PennsylvaniaUnited States | 42.2 | 19.9% | 3.4× | 14 | +47.4% |
| 8 | Post Graduate Institute of Medical Education and ResearchIndia | 40.2 | 3.1% | 8.6× | 13 | +74.6% |
| 9 | Northwestern UniversityUnited States | 39.4 | 27.2% | 3.2× | 10 | +14.3% |
| 10 | University of VirginiaUnited States | 38.7 | 10.8% | 4.0× | 10 | +206.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Eosinophilic Disorders and Syndromes research growing?
Output in 2018–2022 was 19% higher than in 2013–2017, peaking in 2023. The fastest-growing topics are Eosinophilic Disorders and Syndromes.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.